section name header

Pronunciation

LOE-va-sta-tin audio

Indications

REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Poorly and variably absorbed after oral administration.

Distribution: Crosses the blood-brain barrier and placenta.

Metabolism/Excretion: Extensively metabolized by the liver, most during first pass; excreted in bile and feces. 10% excreted unchanged by the kidneys.

Half-life: 3 hr.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CNS: amnesia, confusion, dizziness, headache, insomnia, memory loss, weakness.

EENT: blurred vision.

GI: abdominal cramps, constipation, diarrhea, flatus, heartburn, altered taste, drug-induced hepatitis, dyspepsia, liver enzymes, nausea, pancreatitis.

Endo: hyperglycemia.

GU: erectile dysfunction.

Derm: rashes, pruritus.

MS: RHABDOMYOLYSIS, arthralgia, immune-mediated necrotizing myopathy, myopathy, myositis.

Misc: hypersensitivity reactions.

Interactions

Drug-Drug:

Drug-Natural Products:

Drug-Food:

Route/Dosage

Renal Impairment

Implementation

US Brand Names

Altoprev, Mevacor

Classifications

Therapeutic Classification: lipid-lowering agents

Pharmacologic Classification: hmg coa reductase inhibitors (statin)

Availability

(Generic available)

Time/Action Profile

(cholesterol-lowering effect)

ROUTEONSETPEAKDURATION
PO, PO-ER2 wk4–6 wk6 wk

†After discontinuation.

Assessment

Lab Test Considerations:

Pot. Nursing Diagnoses

Patient/Family Teaching

Evaluation/Desired Outcomes

Pill Image

lovastatin_195_8765.jpg

Code

NDC Code*